Literature DB >> 8577084

Behçets disease in children.

P Pivetti-Pezzi1, M Accorinti, M A Abdulaziz, M La Cava, M Torella, D Riso.   

Abstract

Ophthalmic and clinical analysis were carried out on 16 children and 122 adult patients affected by Behçet's disease (BD) to delineate the clinical features of BD in childhood and to investigate the differences between the expression of the disease in children and adults. The mean follow-up period was 7.8 and 7 years, respectively. Pediatric onset of BD was found in 7.6% of all the cases with a male:female ratio of 1.29:1. The complete type of the disease was observed in 50% of the children. No statistical significant differences were noted between children and adults in the incidence of oral aphthae, genital ulcers, skin lesions, arthritis, gastrointestinal involvement, neuropsychiatric symptoms and the presence of HLA-B51. Thrombophlebitis was associated with the onset of the disease in adult age (P=0.022). Uveitis alone or in combination with other major symptoms was the presenting sign in a higher percentage of children (P=0.077), As in adults, in children diffuse uveitis was the most common type of ocular inflammation, while ocular complications have been found mainly in children (P=0.021), who more frequently developed cataract, maculopathy and retinal detachment (P=0.024). Both adult and young male patients have shown a lower age at onset and higher rate of optic atrophy than females. In conclusion, no significant differences have been found between children and adults in the expression of the major and most of the minor symptoms of BD. Ocular involvement in childhood may be very severe, as was confirmed by the high frequency of diffuse uveitis and ocular complications. Young males, as adult males, showed an earlier onset of the disease and a worse ocular prognosis.

Entities:  

Mesh:

Year:  1995        PMID: 8577084

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  10 in total

Review 1.  The use of immunosuppressive and cytotoxic drugs in non-malignant disease.

Authors:  P A Brogan; M J Dillon
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

2.  Prevalence and clinical aspects of Behcet's disease in the north of Israel.

Authors:  Ilan Krause; Anna Yankevich; Abigail Fraser; Itzhak Rosner; Reuven Mader; Devy Zisman; Nina Boulman; Michael Rozenbaum; Abraham Weinberger
Journal:  Clin Rheumatol       Date:  2006-08-01       Impact factor: 2.980

Review 3.  Pediatric Behçet's disease - clinical aspects and current concepts.

Authors:  Mehmet Yıldız; Oya Köker; Amra Adrovic; Sezgin Şahin; Kenan Barut; Özgür Kasapçopur
Journal:  Eur J Rheumatol       Date:  2019-09-05

4.  Challenges of childhood uveitis.

Authors:  Reem Abdwani
Journal:  Sultan Qaboos Univ Med J       Date:  2009-12-19

Review 5.  Current perspectives on ophthalmic manifestations of childhood rheumatic diseases.

Authors:  Neal V Palejwala; Steven Yeh; Sheila T Angeles-Han
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

6.  Cyclosporin A therapy in refractory non-infectious childhood uveitis.

Authors:  D J Kilmartin; J V Forrester; A D Dick
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

Review 7.  Ocular complications of childhood rheumatic diseases: uveitis.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.686

Review 8.  Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features.

Authors:  Paolo Mora; Chiara Menozzi; Jelka G Orsoni; Pierangela Rubino; Livia Ruffini; Arturo Carta
Journal:  Orphanet J Rare Dis       Date:  2013-01-29       Impact factor: 4.123

Review 9.  Behçet's disease in children, an overview.

Authors:  Isabelle Koné-Paut
Journal:  Pediatr Rheumatol Online J       Date:  2016-02-18       Impact factor: 3.054

10.  Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network.

Authors:  Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Giacomo Emmi; Stefano Gentileschi; Carla Gaggiano; Luisa Ciarcia; Virginia Berlengiero; Mariam Mourabi; Nicola Ricco; Sara Barneschi; Irene Mattioli; Gian Marco Tosi; Bruno Frediani; Maria Tarsia; Gerardo di Scala; Antonio Vitale; Florenzo Iannone; Claudia Fabiani; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2021-04-09       Impact factor: 3.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.